• Users Online: 1344
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2013  |  Volume : 15  |  Issue : 1  |  Page : 9-13

Acinetobacter infections: A growing threat in the hospital

1 Graded Specialist (Microbiology), Department of Pathology, INHS Asvini, Colaba, Mumbai-05, India
2 Consultant and HOD Pathology, Department of Pathology, INHS Asvini, Colaba, Mumbai-05, India
3 Classified Specialist (Pathology), Department of Pathology, INHS Asvini, Colaba, Mumbai-05, India
4 PG Resident, Department of Pathology, INHS Asvini, Colaba, Mumbai-05, India

Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0975-3605.203284

Rights and Permissions

Acinetobacter baumannii is a Gram Negative coccobacilli implicated in causation of wide spectrum of nosocomial infections. Multidrug resistant Acinetobacter (MDR Acinetobacter) is emerging as an important cause of hospital acquired infections like urinary tract infection, ventilator associated pneumonia, meningitis, bacteremia and infection in burns patients. The purpose of this study is to determine the prevalence of Acinetobacter infections and ascertain the burden of MDR Acinetobacter in this hospital. This study is a retrospective review of Microbiology laboratory culture reports during the period 01 Jan 2012 to 31 Dec 2012 at INHS Asvini and includes 172 isolates of Acinetobacter baumannii. Multidrug resistant Acinetobacter was defined as resistance to more than three classes of antibiotics. Out of a total of3283 different isolates from various clinical samples during this period, 172 isolates of Acinetobacter baumannii were obtained. Antimicrobial susceptibility patterns for all available antibiotic classes for Acinetobacter were studied. Of all the Acinetobacter baumannii isolated, 38% were found to be Multidrug resistant which were resistant to most of the commonly used antibiotics including Aminoglycosides, Cephalosporins, Carbepenems, Extended Spectrum Penicillins and Fluroquinolones. The data suggests that Acinetobacter infections are a growing threat affecting a considerable proportion of critically ill patients.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded125    
    Comments [Add]    

Recommend this journal